The annual AusBiotech conference is a key event to discuss pivotal issues and emerging topics facing the life sciences & biotech industry in Australia, attracting delegates from around the world.
This year, Spruson & Ferguson experts have been involved in developing parts of the programme, particularly the AgriBiotech section, and will feature in two key panel sessions. Find further detail of these below and please reach out to our Key Team Members directly if you would like to connect.
We hope to see you there!
Details: 30 Oct – 1 Nov 2024, Melbourne Convention & Exhibition Centre
Main programme
Practical & legal considerations of deploying AI in the biotech sector – now and future – Friday 1 November, 2.10pm
AI is proving to be a useful time-saver for many industries, but in terms of discovery, development and ultimately intellectual property (IP) ownership in the biotech industry, where are the boundaries and what are the best uses for these developing technologies? Framing the discussion using the recent release of the Australian Government’s Voluntary AI Safety Standards, Sylvie will guide the panel through several topical issues:
what AI is currently being used for in the biotech landscape
practical challenges of utilising AI in creating or commercialising inventions
what role can AI play or shape the biotech industry for the next five to ten years?
positive impacts and/or concerns
legal challenges associated with protection of AI inventions
Peter will chair this fascinating panel discussion with investor perspectives from both the public and private sectors. Panellists will share their experiences, including what worked, what didn’t, and what surprised them, over the various stages of the innovation journey, from early-stage R&D to investment and impact.
Panellists
Michelle Goldsmith, Chief Executive Officer, Agriculture Victoria Services
Dr Andrew Kelly, Executive Director, Bio Pacific Partners
Dr Chris Nave, Managing Director & Managing Partner, Brandon Capital Partners
Steve Torso, Co-Founder & Managing Director, Wholesale Investor
Sylvie is a lawyer, notary public as well as a registered Australian Patent and Trade Mark Attorney and has over 20 years of experience in the IP field. Sylvie…
Sylvie is a lawyer, notary public as well as a registered Australian Patent and Trade Mark Attorney and has…
Peter has more than 14 years’ experience as a patent attorney specialising in biotechnology, and has built a reputation as a specialist in food & beverage technology, nutraceuticals and…
Peter has more than 14 years’ experience as a patent attorney specialising in biotechnology, and has built a reputation…
Michelle is a patent attorney with over 9 years’ experience in advising on patent and designs protection, portfolio management and IP strategy to Australian and overseas clients. She is…
Michelle is a patent attorney with over 9 years’ experience in advising on patent and designs protection, portfolio management…
Ean is a Principal in Spruson & Ferguson’s Chemical/Life Sciences team in Australia. He is an experienced patent attorney specialising in biotechnology, qualified to practice in Australia, New Zealand,…
Ean is a Principal in Spruson & Ferguson’s Chemical/Life Sciences team in Australia. He is an experienced patent attorney…
Catherine Winbanks is a Principal in our Melbourne biotechnology team.
Catherine specialises in patent matters for the biotechnology, agricultural and life sciences sectors. She practices in prosecuting and overseeing patent…
Catherine Winbanks is a Principal in our Melbourne biotechnology team.
Catherine specialises in patent matters for the biotechnology, agricultural and…
Matthew completed a Bachelor of Science in Medical, Forensic and Analytical Chemistry from Victoria University, graduating with First Class Honours in 2003. In 2009 Matthew was awarded a PhD…
Matthew completed a Bachelor of Science in Medical, Forensic and Analytical Chemistry from Victoria University, graduating with First Class…